Fang Zheng Selected Research

Fang Zheng Research Topics

Disease

79	Neoplasms (Cancer) 01/2022 - 03/2004
25	Inflammation (Inflammations) 02/2022 - 01/2007
23	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 03/2013
23	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2010
16	COVID-19 01/2022 - 01/2020
16	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 04/2009
10	Rheumatoid Arthritis 07/2019 - 01/2010
9	Infections 03/2022 - 01/2009
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2005
9	Hepatitis 12/2020 - 01/2010
9	Seizures (Absence Seizure) 01/2017 - 04/2007
8	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2004
8	Alzheimer Disease (Alzheimer's Disease) 08/2019 - 11/2004
7	Atherosclerosis 01/2022 - 01/2006
6	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 11/2016
6	Pain (Aches) 11/2021 - 02/2010
6	Neoplasm Metastasis (Metastasis) 04/2021 - 02/2009
6	Carcinogenesis 01/2020 - 09/2005
6	Coronary Disease (Coronary Heart Disease) 01/2014 - 04/2004
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2022 - 03/2015
5	Type 2 Diabetes Mellitus (MODY) 07/2021 - 12/2005
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2009
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2010
5	Multiple Sclerosis 01/2021 - 02/2012
5	Substance-Related Disorders (Drug Abuse) 10/2020 - 01/2012
5	Melanoma (Melanoma, Malignant) 11/2018 - 09/2011
5	Cataract (Cataracts) 06/2015 - 03/2008
4	Body Weight (Weight, Body) 09/2022 - 01/2008
4	Fibrosis (Cirrhosis) 03/2021 - 01/2021
4	Schizophrenia (Dementia Praecox) 02/2021 - 06/2012
4	Disease Progression 01/2020 - 01/2009
4	Nasopharyngeal Carcinoma 01/2019 - 07/2014
4	Colitis 01/2019 - 07/2012
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2018 - 02/2008
4	Ischemia 01/2018 - 06/2008
4	Ovarian Neoplasms (Ovarian Cancer) 07/2004 - 11/2002
3	Demyelinating Diseases (Demyelinating Disease) 11/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2019
3	Hypoxia (Hypoxemia) 01/2022 - 09/2016
3	Stomach Neoplasms (Stomach Cancer) 04/2021 - 09/2016

Drug/Important Bio-Agent (IBA)

51	Proteins (Proteins, Gene)FDA Link 02/2022 - 12/2002
21	Pharmaceutical PreparationsIBA 06/2022 - 11/2009
19	Biomarkers (Surrogate Marker)IBA 06/2022 - 02/2011
19	Cocaine (Cocaine HCl)IBA 01/2022 - 03/2013
15	EnzymesIBA 01/2022 - 12/2011
14	HMGB1 Protein (HMG1)IBA 11/2022 - 06/2008
13	CytokinesIBA 01/2022 - 12/2012
12	Biological ProductsIBA 09/2022 - 09/2011
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2006
11	MicroRNAs (MicroRNA)IBA 06/2020 - 02/2012
10	Messenger RNA (mRNA)IBA 01/2022 - 04/2009
10	Interleukin-33IBA 01/2021 - 07/2012
9	Retinaldehyde (Retinal)IBA 04/2021 - 01/2017
8	Long Noncoding RNAIBA 01/2020 - 01/2015
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 03/2004
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
6	Immunoglobulin G (IgG)IBA 12/2020 - 08/2014
6	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2002
6	Pilocarpine (Ocusert)FDA LinkGeneric 01/2017 - 08/2009
5	C-Reactive ProteinIBA 01/2021 - 02/2007
5	Interleukin-10 (Interleukin 10)IBA 10/2020 - 01/2007
5	cocaine hydrolaseIBA 01/2020 - 05/2014
5	oxidized low density lipoproteinIBA 06/2019 - 04/2004
5	p38 Mitogen-Activated Protein KinasesIBA 01/2019 - 04/2014
5	Concanavalin AIBA 01/2017 - 01/2010
5	MethyltransferasesIBA 01/2017 - 03/2015
4	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 12/2005
4	VaccinesIBA 01/2022 - 04/2012
4	Therapeutic UsesIBA 01/2021 - 01/2016
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2011
4	BerberineIBA 01/2021 - 04/2014
4	CollagenIBA 01/2021 - 01/2005
4	LipidsIBA 01/2020 - 08/2013
4	beta-solamarineIBA 11/2019 - 12/2015
4	ErbB Receptors (EGF Receptor)IBA 07/2019 - 01/2014
4	CalreticulinIBA 07/2019 - 07/2013
4	ApolipoproteinsIBA 06/2019 - 11/2004
4	Apolipoproteins E (ApoE)IBA 06/2019 - 04/2004
4	Dinoprostone (PGE2)FDA Link 01/2019 - 12/2013
4	LDL Receptors (LDL Receptor)IBA 08/2018 - 02/2008
4	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2014
4	Single-Domain AntibodiesIBA 01/2017 - 05/2014
4	Ursolic AcidIBA 05/2016 - 04/2015
4	AntigensIBA 01/2016 - 04/2012
4	Caspase 3 (Caspase-3)IBA 07/2004 - 11/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 04/2016
3	Monoclonal AntibodiesIBA 01/2022 - 10/2018
3	NucleotidesIBA 01/2022 - 07/2019
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 01/2014
3	Analgesics (Analgesic Drugs)IBA 11/2021 - 07/2015
3	pristane (pristan)IBA 01/2021 - 01/2010
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2020
3	Immunoglobulin M (IgM)IBA 12/2020 - 02/2018
3	AntibodiesIBA 12/2020 - 01/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020 - 01/2018

Therapy/Procedure

36	Therapeutics 01/2022 - 11/2009
6	Drug Therapy (Chemotherapy) 01/2020 - 12/2002
4	Immunotherapy 01/2022 - 04/2012
4	Radiofrequency Ablation 02/2017 - 10/2010